CASE STUDIES

How We Drive Commercial Growth

Real results from strategic commercial leadership in medtech. These case studies show how clear strategy, disciplined execution, and customer-driven thinking translate into measurable business impact.

From Regional Fragmentation to +29% Revenue Growth

Product Launch Coordination & Commercial Alignment

THE SITUATION

A regional medtech business across 13 APAC markets was managing concurrent product launches with different regulatory requirements, reimbursement structures, and buyer readiness. Launch coordination was fragmented, with no unified requirements framework and unclear prioritization.

THE CHALLENGE

Medtech launches compound in complexity at scale. Regulatory approval timelines vary, clinical evidence needs differ by market, and distributor readiness is inconsistent. Without one decision-making lens, launches slip and competitive windows close.

THE APPROACH

Built an integrated launch roadmap system with Regulatory, Clinical, Quality, and Commercial teams, defining unified product requirements, a cross-functional decision framework, GTM sequencing, and launch-risk mitigation routines.

RESULTS

✓ +29% revenue growth in Year 1 through disciplined launch execution
✓ Integrated A&E Medical acquisition across 12 countries without delays
✓ Repeatable launch governance model adopted across subsequent introductions
✓ Built team capability in cross-functional delivery and stakeholder alignment

When product strategy, requirements discipline, and cross-functional alignment are clear, launches execute faster, revenue scales predictably, and teams move with confidence.

Building Pipeline from Intelligence & Positioning

Commercial Intelligence, Portfolio Positioning & Demand Generation

THE SITUATION

A multi-country capital equipment and digital solutions portfolio was operating with minimal visibility into customer priorities, competitive threats, or win/loss drivers. Sales conversion sat at 7% despite healthy deal volume.

THE CHALLENGE

Long sales cycles and multiple buyer personas create friction. Without structured customer insight and competitive intelligence, positioning becomes defensive, resources scatter, and pipeline sits flat.

THE APPROACH

Designed a commercial intelligence program with structured VOC research, Salesforce and Power BI pipeline analytics, competitive assessment, outcome-led positioning, and coaching for data-driven decision-making.

RESULTS

✓ Generated $145M opportunity pipeline over the engagement period. ✓ Improved sales conversion from 7% to 33% through targeted positioning and customer alignment. ✓ Enabled portfolio prioritization grounded in customer insight. ✓ Built repeatable intelligence processes adopted across markets.

Commercial leadership is not just marketing campaigns—it is building the infrastructure that lets your sales team win with confidence.

Disciplined Portfolio Rationalization & Commercial Clarity

Portfolio Prioritization & Requirements-Led Decision Making

A complex implant and instrument portfolio included 103 underperforming product lines and 20,000+ SKUs. By creating a performance, margin, growth, and strategic-fit framework, the team could rationalize with clarity, protect customers, reduce operational drag, and create capacity for higher-impact innovation.

RESULTS

✓ Rationalized 103 underperforming product lines with clear commercial rationale. ✓ Improved portfolio efficiency and supply chain cost structure. ✓ Strengthened credibility with global leadership through disciplined decisions. ✓ Created capacity for strategic focus on high-impact innovation.

Fractional CMO work often means creating the strategic clarity and decision-making frameworks that let organizations move decisively.

Why Medtech Organizations Choose Fractional CMO Partnerships

Each case illustrates a distinct challenge—launch coordination, pipeline generation, portfolio clarity. But they share the same pattern: clear commercial strategy + disciplined cross-functional execution = measurable business impact.

Regulatory & market complexity demands clear thinking

Medtech has more moving parts than most industries. Fractional CMO work installs the strategic frameworks that keep complexity organized.

Teams are underresourced for commercial leadership

Most medtech organizations lack a dedicated CMO or marketing leader with P&L accountability. Fractional CMO work fills that gap at a fraction of full-time cost.

Leadership transitions are expensive & risky

Permanent CMO hiring is lengthy, risky, and costly. Fractional engagement lets you test fit, build capability, and move faster while you decide on full-time structure.

Good strategy outlasts the engagement

The frameworks, processes, and team capability built during fractional work continue to drive value long after the engagement ends.

Ready to Build Commercial Clarity?

Let’s talk about your commercial challenges and what a fractional CMO engagement might look like for your business.

Start a Conversation